Veralipride
| Title | Journal |
|---|---|
| [Consensus conference of the Mexican Association for the Study of Climateric on veralipride prescription for patients with vasomotor symptoms]. | Ginecologia y obstetricia de Mexico 20120701 |
| Preparation, spectroscopic and thermal characterization of new metal complexes of verlipride drug. In vitro biological activity studies. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120601 |
| Modelling the Double Peak Phenomenon in pharmacokinetics. | Computer methods and programs in biomedicine 20111101 |
| [Parkinsonism induced by sulpiride and veralipride: two different stories]. | Medicina clinica 20111015 |
| Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes. | Climacteric : the journal of the International Menopause Society 20100401 |
| Bioactivity of isoflavones: assessment through a theoretical model as a way to obtain a 'Theoretical Efficacy Related to Estradiol (TERE)'. | International journal of molecular sciences 20100101 |
| Actual status of veralipride use. | Clinical interventions in aging 20100101 |
| Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions. | International journal of women's health 20100101 |
| Pharmacological causes of hyperprolactinemia. | Therapeutics and clinical risk management 20071001 |
| Reversible jump Markov chain Monte Carlo for deconvolution. | Journal of pharmacokinetics and pharmacodynamics 20070601 |
| Treatment of premature menopause in breast cancer patients. | Acta chirurgica Belgica 20070601 |
| Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review. | Climacteric : the journal of the International Menopause Society 20070201 |
| Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. | Drug safety 20070101 |
| Tardive blepharospasm beginning after withdrawal of veralipride. | Movement disorders : official journal of the Movement Disorder Society 20061101 |
| The safety of veralipride. | Expert opinion on drug safety 20060901 |
| Veralipride-induced acute coronary syndrome unmasking a non-secreting pheochromocytoma. | Journal of endocrinological investigation 20060101 |
| [Clinical guide to the menopause and post-menopause]. | Atencion primaria 20050930 |
| The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption. | Pharmaceutical research 20050801 |
| [Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases]. | La Revue de medecine interne 20050601 |
| Tardive dyskinesia after long-term veralipride treatment. | The Journal of neuropsychiatry and clinical neurosciences 20050101 |
| Predictors of hot flushes in postmenopausal women who receive raloxifene therapy. | American journal of obstetrics and gynecology 20041201 |
| [Post-menopausal hot flushes and parkinsonism]. | Revista de neurologia 20041101 |
| Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20040401 |
| Alternatives to estrogen. | The Medical clinics of North America 20030901 |
| Cimicifuga extract BNO 1055: reduction of hot flushes and hints on antidepressant activity. | Maturitas 20030314 |
| [Drug-induced hyperprolactinemia: a case-non-case study from the national pharmacovigilance database]. | Therapie 20030101 |
| The Women's Health Questionnaire (WHQ): Frequently Asked Questions (FAQ). | Health and quality of life outcomes 20030101 |
| Modification of vasomotor symptoms after various treatment modalities in the postmenopause. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20010501 |
| Worsening of Parkinsonism after the use of veralipride for treatment of menopause: case report. | Arquivos de neuro-psiquiatria 20010301 |
| Macrophage Fcgamma receptors expression is altered by treatment with dopaminergic drugs. | Clinical immunology (Orlando, Fla.) 19990301 |
| [Parkinson syndrome induced by veralipride]. | Minerva ginecologica 19950601 |
| [Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases]. | Therapie 19950101 |
| Veralipride-induced tardive dystonia in a patient with bipolar psychosis. | Italian journal of neurological sciences 19921001 |